SWX:DKSHTrade Distributors
DKSH Holding (SWX:DKSH) Could Be 7% Below Fair Value After Eli Lilly Deal
DKSH Holding (SWX:DKSH) is in focus after its healthcare unit signed an agreement with Eli Lilly Export S.A. to sell, promote, and distribute Lilly’s pharmaceutical portfolio in Hong Kong and Macau.
See our latest analysis for DKSH Holding.
The Lilly agreement comes at a time when DKSH Holding’s momentum has been firm, with a 30 day share price return of 8.16% and a year to date share price return of 15.36%, while the 1 year total shareholder return of 18.60% points to steady longer term...